menu
    • menu

    Company profile for Quoin Pharmaceuticals

    NEW Drugs in Dev: 3
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2018, Quoin (QNRX) is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indicat...
    Founded in 2018, Quoin (QNRX) is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quoin PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    42127 Pleasant Forest Court Ashburn​, VA, 20148-7349
    Telephone
    Telephone
    (703) 980-4182
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quoinpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quoin-pharmaceuticals/?trk=ppro_cprof&originalSubdomain=uk
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ELCC

    ELCC

    Not Confirmed

    envelop Contact Supplier

    ELCC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quoin Pharma Updates Corporate Status, Reveals 2025 Financials
    Quoin Pharma Updates Corporate Status, Reveals 2025 Financials

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263001/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Quoin Pharma Updates FDA On QRX003 For Netherton Syndrome
    Quoin Pharma Updates FDA On QRX003 For Netherton Syndrome

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262173/0/en/Quoin-Pharmaceuticals-Provides-Clinical-and-Regulatory-Update-from-Constructive-Type-C-Meeting-with-U-S-FDA-for-QRX003-in-Netherton-Syndrome.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Quoin Pharma To Unveil Corporate Update And 2025 Financial Result
    Quoin Pharma To Unveil Corporate Update And 2025 Financial Result

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258994/0/en/Quoin-Pharmaceuticals-to-Announce-Corporate-Update-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Thursday-March-26-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Quoin Pharma Gets FDA Fast Track For QRX003 In Netherton Syndrome
    Quoin Pharma Gets FDA Fast Track For QRX003 In Netherton Syndrome

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/11/3253756/0/en/Quoin-Pharmaceuticals-Announces-FDA-Grants-Fast-Track-Designation-for-QRX003-for-the-Treatment-of-Netherton-Syndrome.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Netherton Now Spotlights Netherton Syndrome on Rare Disease Day
    Netherton Now Spotlights Netherton Syndrome on Rare Disease Day

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245592/0/en/NETHERTON-NOW-Recognizes-Rare-Disease-Day-and-Highlights-Growing-Global-Awareness-of-Netherton-Syndrome.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Quoin Submits QRX003 For Orphan Designation In Netherton Syndrome
    Quoin Submits QRX003 For Orphan Designation In Netherton Syndrome

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226489/0/en/Quoin-Pharmaceuticals-Announces-Submission-to-Japanese-MHLW-for-Orphan-Drug-Designation-for-QRX003-in-Netherton-Syndrome.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search